These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15765429)

  • 41. Proton pump inhibitors: effective first-line treatment for management of dyspepsia.
    Peura DA; Gudmundson J; Siepman N; Pilmer BL; Freston J
    Dig Dis Sci; 2007 Apr; 52(4):983-7. PubMed ID: 17342402
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proton pump inhibitors prescribing following the introduction of generic drugs.
    Cammarota S; Bruzzese D; Sarnelli G; Citarella A; Menditto E; Riegler S; Savino IG; Vozzella L; Piccinocchi G; Napoli L; Arpino G; Cuomo R
    Eur J Clin Invest; 2012 Oct; 42(10):1068-78. PubMed ID: 22681176
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is there any effect of sequential eradication therapy of helicobacter pylori on functional dyspepsia symptom resolution?
    Sarikaya M; Filik L; Doğan Z; Ergül B
    Acta Gastroenterol Belg; 2013 Dec; 76(4):448-9. PubMed ID: 24592555
    [No Abstract]   [Full Text] [Related]  

  • 44. The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal.
    Savarino V; Dulbecco P; de Bortoli N; Ottonello A; Savarino E
    Eur J Intern Med; 2017 Jan; 37():19-24. PubMed ID: 27784575
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dyspepsia and reflux in primary care: rough DIAMOND of a trial.
    van Zanten SV
    Lancet; 2009 Jan; 373(9659):187-8. PubMed ID: 19150689
    [No Abstract]   [Full Text] [Related]  

  • 46. An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews.
    Moayyedi P; Deeks J; Talley NJ; Delaney B; Forman D
    Am J Gastroenterol; 2003 Dec; 98(12):2621-6. PubMed ID: 14687807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 10-minute consultation: Dyspepsia.
    Delaney BC
    BMJ; 2001 Mar; 322(7289):776. PubMed ID: 11282866
    [No Abstract]   [Full Text] [Related]  

  • 48. A multicenter double-blind study of sulglycotide versus sucralfate in nonulcer dyspepsia.
    Psilogenis M; Nazzari M; Ferrari PA
    Int J Clin Pharmacol Ther Toxicol; 1990 Sep; 28(9):369-74. PubMed ID: 2228322
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Update on current care guidelines. A current care guideline: recurrent upper gastrointestinal symptoms].
    Paikka N
    Duodecim; 2012; 128(22):2376-7. PubMed ID: 23342484
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reducing community dyspepsia drug costs: a controlled trial.
    Valori RM; Brown CM; Strangeways P; Bradburn M
    Gut; 2001 Oct; 49(4):495-501. PubMed ID: 11559645
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost-effectiveness of and satisfaction with a Helicobacter pylori "test and treat" strategy compared with prompt endoscopy in young Asians with dyspepsia.
    Mahadeva S; Chia YC; Vinothini A; Mohazmi M; Goh KL
    Gut; 2008 Sep; 57(9):1214-20. PubMed ID: 18441005
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Observational comparative trial of the efficacy of proton pump inhibitors versus histamine-2 receptor antagonists for uninvestigated dyspepsia.
    Nagahara A; Asaoka D; Hojo M; Oguro M; Shimada Y; Ishikawa D; Osada T; Kawabe M; Yoshizawa T; Otaka M; Watanabe S
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S122-8. PubMed ID: 20586853
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Should Helicobacter pylori be eradicated in patients with functional dyspepsia?].
    Elizalde I; Borda F
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 2():43-6. PubMed ID: 11968334
    [No Abstract]   [Full Text] [Related]  

  • 54. What's new: proton pump inhibitors and pediatrics.
    Patel AS; Pohl JF; Easley DJ
    Pediatr Rev; 2003 Jan; 24(1):12-5. PubMed ID: 12509540
    [No Abstract]   [Full Text] [Related]  

  • 55. [Role of acid in functional dyspepsia].
    Tomita T; Oshima T; Fukui H; Watari J; Miwa H
    Nihon Rinsho; 2015 Jul; 73(7):1202-8. PubMed ID: 26165081
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Benefit of supplements in functional dyspepsia after treatment of Helicobacter pylori.
    Pellicano R; Ribaldone DG; Saracco GM; Leone N; De Angelis C; Arrigoni A; Morello E; Sapone N; Cisarò F; Astegiano M
    Minerva Gastroenterol Dietol; 2014 Dec; 60(4):263-8. PubMed ID: 25384804
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The efficiency of Levofloxacin Containing Sequential Therapy with or without Bismuth, in Helicobacter Pylori Eradication, in Non-ulcer Dyspepsia.
    Celik M; Yigit M
    Acta Gastroenterol Belg; 2017; 80(1):39-42. PubMed ID: 29364096
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discontinuation of long-term proton pump inhibitor therapy in primary care patients: a randomized placebo-controlled trial in patients with symptom relapse.
    Reimer C; Bytzer P
    Eur J Gastroenterol Hepatol; 2010 Oct; 22(10):1182-8. PubMed ID: 20664352
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Can dietary integrators provide a clinical benefit in the treatment of functional dyspepsia? results from a prospective study with TUBES Gastro.
    Molteni M
    Minerva Gastroenterol Dietol; 2014 Jun; 60(2):105-12. PubMed ID: 24780944
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Gastroesophageal reflux disease and dyspepsia--drug therapy].
    Gräter H
    Praxis (Bern 1994); 2006 Aug; 95(31-32):1179-83. PubMed ID: 16909686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.